Free to read. Sign up to save your progress and take knowledge-check quizzes.

Sign up free
5 min read·Updated July 2, 2026

Ash by Slingshot AI

Slingshot AI logoBy Slingshot AI

Ash is a consumer AI therapy chatbot from Slingshot AI, grounded in evidence-based techniques such as CBT, DBT, and ACT — a well-funded pure-play in a category whose safety and efficacy are still being validated, and best understood as support rather than a replacement for licensed care.

Listen to this lesson

Free preview · first 0:30
0:00 / 0:30

Audio & video lessons are paid features

Plus unlocks audio streaming. Pro adds downloadable audio, video, certificates, and more.

Plus adds:
  • Audio streaming
  • Downloadable PDFs
  • All AI Playbooks
  • Personalized content
Pro also adds:
  • Certificates of completion
  • Audio MP3 downloads
  • Video lessonssoon
  • & More…soon

Watch this lesson

AI Pro Playbook video — coming soon

Learning Objectives

  • Understand what Ash is and the techniques it draws on
  • Weigh the genuine promise of AI mental-health support against its real risks
  • Evaluate why this category faces active regulatory and clinical scrutiny

What Is Ash?

Ash is a consumer AI therapy chatbot built by Slingshot AI, a company describing itself as building a "foundation model for psychology." Ash holds text conversations grounded in evidence-based therapeutic techniques — cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and acceptance and commitment therapy (ACT) — to help users work through everyday stress, anxious thoughts, and emotional challenges. Backed by Andreessen Horowitz and others, Slingshot launched Ash in July 2025 and reported rapid early adoption.

Ash sits at the center of one of the most consequential and contested areas in healthcare AI: whether conversational agents can safely deliver mental-health support at scale. The promise is real — the shortage of human therapists is severe, cost and stigma keep many people from care, and an always-available, low-cost tool could reach people who would otherwise get nothing. But the risks are equally real: clinical validity, crisis handling, and the dangers of an always-on bot for vulnerable users. Ash's early self-published outcomes were criticized for lacking a control group, and AI therapy chatbots broadly drew regulatory scrutiny — including a November 2025 FDA advisory-panel discussion. The honest framing is that this category's efficacy and safety questions are still being worked out, and Ash is best understood as support, not a replacement for licensed care.

💡Key Concept

Support, not treatment: Ash applies recognized therapeutic techniques in conversation, but it is not a licensed clinician and does not provide diagnosis or treatment. It is best thought of as accessible, low-cost emotional support that can complement — not substitute for — professional mental-health care.

⚠️Warning

A genuinely high-stakes category. AI mental-health tools carry serious risks: mishandling a crisis, giving poor guidance, or fostering unhealthy reliance in vulnerable users. Efficacy evidence is still early and contested, and regulators are actively examining the space. Anyone in crisis should contact a human crisis line or professional, not a chatbot.

Tip

Visit Slingshot AI: slingshot.ai — Ash is available as a consumer application.

Pricing

Ash is offered as a consumer application, typically with free access to core features and a paid subscription for more. Because it is a wellness and support tool rather than a covered medical service, it is generally paid out of pocket.

FreeNo cost
  • Core conversational support
  • Evidence-based techniques
  • General access
SubscriptionConsumer subscription
  • Expanded features and usage
  • Ongoing support
  • Out-of-pocket

Core Features

Conversational Support

Holds text conversations that apply therapeutic techniques to everyday stress, anxious thinking, and emotional challenges, available whenever the user needs it.

Evidence-Based Techniques

Draws on CBT, DBT, and ACT — established, well-studied frameworks — as the basis for how it guides conversations.

Always-Available Access

Offers low-cost, on-demand support that can reach people who face cost, stigma, or availability barriers to human care.

Foundation Model for Psychology

Slingshot frames Ash as built on a model specialized for psychological conversation rather than a general-purpose chatbot repurposed for the task.

Strengths

  • Addresses a severe access gap — far too few human therapists for the need
  • Grounded in established techniques — CBT, DBT, and ACT rather than ad-hoc responses
  • Always available and low cost — reaches people blocked by cost, stigma, or availability
  • Well-funded pure-play — a serious, dedicated company in the space
  • Specialized model — built for psychological conversation, not a general chatbot

Limitations and Considerations

  • Not a licensed clinician — no diagnosis, treatment, or crisis care
  • Efficacy evidence is early and contested — including critiques of uncontrolled outcome studies
  • Crisis handling is a serious risk — chatbots can mishandle emergencies
  • Regulatory scrutiny is active — the category faces open questions from regulators
  • Reliance risk — vulnerable users may over-rely on an always-on bot

Best Use Cases

Use CaseWhy Ash FitsCaveat
Everyday stress and anxious thinkingApplies CBT, DBT, and ACT techniques on demandNot a substitute for therapy
Low-barrier first step to supportFree, always available, low stigmaEscalate to a professional when needed
Between-session self-helpComplements human careCoordinate with a clinician if in treatment
Access where care is scarceReaches people blocked from human careNot appropriate for crises

Key Takeaways

  • Ash is a consumer AI therapy chatbot from Slingshot AI, applying evidence-based techniques — CBT, DBT, and ACT — to everyday emotional challenges
  • The promise is real: it addresses a severe shortage of human therapists and reaches people blocked by cost, stigma, or availability
  • The risks are equally real: clinical validity, crisis handling, and reliance, with efficacy evidence still early and contested
  • The category faces active regulatory scrutiny, including a November 2025 FDA advisory-panel discussion
  • Ash is best understood as accessible support, not a replacement for licensed care — and it is not appropriate for anyone in crisis

Save your progress & take the quiz

Sign up free to bookmark lessons, track which modules you've completed, and lock in what you learned with a quick knowledge-check quiz at the end of each lesson.

🧭Recommended for you